Australia · Delayed Price · Currency is AUD Atlas Arteria Statistics
Total Valuation
Atlas Arteria has a market cap or net worth of AUD 6.96 billion. The enterprise value is 8.41 billion.
| Market Cap | 6.96B |
| Enterprise Value | 8.41B |
Important Dates
The last earnings date was Wednesday, February 25, 2026.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | Sep 24, 2025 |
Share Statistics
Atlas Arteria has 1.45 billion shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 1.45B |
| Shares Outstanding | 1.45B |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +0.64% |
| Owned by Insiders (%) | 0.12% |
| Owned by Institutions (%) | 74.07% |
| Float | 1.45B |
Valuation Ratios
The trailing PE ratio is 26.84 and the forward PE ratio is 16.20. Atlas Arteria's PEG ratio is 0.43.
| PE Ratio | 26.84 |
| Forward PE | 16.20 |
| PS Ratio | 43.53 |
| PB Ratio | 1.20 |
| P/TBV Ratio | 1.85 |
| P/FCF Ratio | 79.50 |
| P/OCF Ratio | 78.96 |
| PEG Ratio | 0.43 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.25, with an EV/FCF ratio of 96.02.
| EV / Earnings | 32.41 |
| EV / Sales | 52.57 |
| EV / EBITDA | 26.25 |
| EV / EBIT | 33.85 |
| EV / FCF | 96.02 |
Financial Position
The company has a current ratio of 2.17, with a Debt / Equity ratio of 0.30.
| Current Ratio | 2.17 |
| Quick Ratio | 2.15 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 34.71 |
| Debt / FCF | 19.65 |
| Interest Coverage | -0.23 |
Financial Efficiency
Return on equity (ROE) is 2.99% and return on invested capital (ROIC) is -0.30%.
| Return on Equity (ROE) | 2.99% |
| Return on Assets (ROA) | -0.17% |
| Return on Invested Capital (ROIC) | -0.30% |
| Return on Capital Employed (ROCE) | -0.30% |
| Weighted Average Cost of Capital (WACC) | 6.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Atlas Arteria has paid 8.00 million in taxes.
| Income Tax | 8.00M |
| Effective Tax Rate | 4.21% |
Stock Price Statistics
The stock price has decreased by -5.33% in the last 52 weeks. The beta is 0.46, so Atlas Arteria's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -5.33% |
| 50-Day Moving Average | 4.81 |
| 200-Day Moving Average | 5.03 |
| Relative Strength Index (RSI) | 52.07 |
| Average Volume (20 Days) | 2,370,252 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Atlas Arteria had revenue of AUD 160.00 million and earned 259.50 million in profits. Earnings per share was 0.18.
| Revenue | 160.00M |
| Gross Profit | 98.20M |
| Operating Income | -22.30M |
| Pretax Income | 189.80M |
| Net Income | 259.50M |
| EBITDA | 49.60M |
| EBIT | -22.30M |
| Earnings Per Share (EPS) | 0.18 |
Balance Sheet
The company has 274.40 million in cash and 1.72 billion in debt, with a net cash position of -1.45 billion or -1.00 per share.
| Cash & Cash Equivalents | 274.40M |
| Total Debt | 1.72B |
| Net Cash | -1.45B |
| Net Cash Per Share | -1.00 |
| Equity (Book Value) | 5.80B |
| Book Value Per Share | 4.00 |
| Working Capital | 155.70M |
Cash Flow
In the last 12 months, operating cash flow was 88.20 million and capital expenditures -600,000, giving a free cash flow of 87.60 million.
| Operating Cash Flow | 88.20M |
| Capital Expenditures | -600,000 |
| Free Cash Flow | 87.60M |
| FCF Per Share | 0.06 |
Margins
Gross margin is 61.38%, with operating and profit margins of -13.94% and 162.19%.
| Gross Margin | 61.38% |
| Operating Margin | -13.94% |
| Pretax Margin | 118.63% |
| Profit Margin | 162.19% |
| EBITDA Margin | 31.00% |
| EBIT Margin | -13.94% |
| FCF Margin | 54.75% |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 8.33%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 8.33% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 223.66% |
| Buyback Yield | -0.03% |
| Shareholder Yield | 8.30% |
| Earnings Yield | 3.73% |
| FCF Yield | 1.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Atlas Arteria has an Altman Z-Score of 2.12 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.12 |
| Piotroski F-Score | 3 |